z-logo
open-access-imgOpen Access
Mutational Analysis of the Adaptor Protein 2 Sigma Subunit (AP2S1) Gene: Search for Autosomal Dominant Hypocalcemia Type 3 (ADH3)
Author(s) -
Angela Rogers,
M. Andrew Nesbit,
Fadil Hannan,
Sarah Howles,
Caroline M. Gorvin,
Treena Cranston,
Jeremy Allgrove,
John S. Bevan,
Gul Bano,
Caroline Brain,
Vipan Datta,
Ashley Grossman,
Shirley V. Hodgson,
Louise Izatt,
Lynne Millar-Jones,
Simon H. S. Pearce,
Lisa Robertson,
Peter Selby,
Brian Shine,
Katie Snape,
Justin Warner,
Rajesh V. Thakker
Publication year - 2014
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2013-3909
Subject(s) - mutation , medicine , endocrinology , gene , biology , chemistry , genetics
Autosomal dominant hypocalcemia (ADH) types 1 and 2 are due to calcium-sensing receptor (CASR) and G-protein subunit-α11 (GNA11) gain-of-function mutations, respectively, whereas CASR and GNA11 loss-of-function mutations result in familial hypocalciuric hypercalcemia (FHH) types 1 and 2, respectively. Loss-of-function mutations of adaptor protein-2 sigma subunit (AP2σ 2), encoded by AP2S1, cause FHH3, and we therefore sought for gain-of-function AP2S1 mutations that may cause an additional form of ADH, which we designated ADH3.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom